277 filings
Page 3 of 14
8-K
siz8yyv7aai3d25l4sg0
3 Oct 18
Entry into a Material Definitive Agreement
8:00am
8-K
zr5camhlo3vw 8hx9uzk
26 Sep 18
Unregistered Sales of Equity Securities
12:00am
8-K
0kmor3 jdejn9
20 Sep 18
ReShape Lifesciences Announces Proposed Public Offering
9:00am
8-K
no8pdlj16yvwmly
14 Sep 18
ReShape Lifesciences Announces Proposed Public Offering
12:00am
8-K
zjcvhd9rfu99i
11 Sep 18
Departure of Directors or Certain Officers
12:00am
8-K
mtk4spm6
28 Aug 18
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
vs7dsvwbnq7c
14 Aug 18
ReShape Lifesciences Announces Second Quarter 2018 Financial Results
4:06pm
8-K
89ceek066z9h d4
13 Aug 18
Termination of a Material Definitive Agreement
8:00am
8-K
xb2 iadom6
2 Aug 18
ReShape Lifesciences Announces Registered Direct Offering
4:09pm
8-K
nlwxv5na 18o60tngnk
13 Jul 18
ReShape Lifesciences Announces $2.7 Million Registered Direct Offering Priced At-the-Market
4:16am
8-K
0o7 2htkgs9
21 Jun 18
ReShape Lifesciences Announces $1.5 Million Registered Direct Offering Priced At-the-Market
8:33am
8-K
281lpxedrkfqal9ro
8 Jun 18
Departure of Directors or Certain Officers
5:14pm
8-K
nf4aesf0
8 Jun 18
ReShape Lifesciences Announces $1.5 Million Registered Direct Offering Priced At-the-Market
8:34am
8-K
5ftow
1 Jun 18
Amendments to Articles of Incorporation or Bylaws
4:09pm
8-K
thbtt9q04ydu
25 May 18
Entry into a Material Definitive Agreement
9:15am
8-K
u6ktm
18 May 18
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
pu6vre7ilfr
14 May 18
ReShape Lifesciences Announces Record Revenue for First Quarter 2018
4:07pm
8-K
kpegnxxxi580w glc9w
24 Apr 18
Departure of Directors or Certain Officers
12:00am
8-K
86fyxwhjek2thznkpfpt
3 Apr 18
Entry into a Material Definitive Agreement
12:00am
8-K
nik8ye5
2 Apr 18
ReShape Lifesciences Announces Fourth Quarter and Year End 2017 Financial Results
12:00am